Hydroxychloroquine study on veteran patients shows no benefits, more deaths among patients using the drug – By Aaron Colen (The Blaze) / April 21 2020
It’s the largest study on the drug so far
A study of the effectiveness of the anti-malarial drug hydroxychloroquine on veterans hospitalized with COVID-19 showed that the drug had no positive impact on those who took it when compared to patients who did not, Politico reported.
The study included 368 patients and is the largest of its kind so far. There has been anecdotal evidence from doctors and patients in the United States and other countries that hydroxychloroquine is an effective treatment for the disease caused by the novel coronavirus that originated in Wuhan, China.
About the study: The researchers looked at the medical records for 368 patients who were hospitalized in veterans facilities with COVID-19, and who either died or were discharged by April 11.
The patients were divided into three categories: Those who took hydroxychloroquine along with standard COVID-19 care; those who took hydroxychloroquine and the antibiotic azithromycin along with standard care; and those who only received standard care.
Continue to article: https://www.theblaze.com/news/hydroxychloroquine-study-on-veteran-patients-shows-no-benefits-more-deaths-among-patients-using-the-drug
